跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
S-116
首页
药物
S-116
S-116
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Synthetic peptide for neurological disorders
US 7264808 B2
申请人: LIPPS BINIE V
优先权: 2003
US
2 件公开
Splicing factor
US 2002115180 A1
申请人: OESTERR FORSCH SEIBERSDORF
优先权: 1999
US
Synthetic peptide as treatment for down's syndrome and schizophrenia
US 2004072744 A1
申请人: LIPPS BINIE V
优先权: 2002
US
Platinum(II) complex with alkoxy carboxylic acid as ligand and antineoplastic characteristic
CN 1680410 A
申请人: NANJING UNIVERSITY OF TECHNOLOGY
优先权: 2004
CN
METHOD FOR TREATING CANCERS WITH INCREASED RAS SIGNALING
US 2009220503 A1
申请人: UNIV BOSTON
优先权: 2007
US
TRIARYLAMINE DERIVATIVE
US 2008255387 A1
申请人: MASAKI TOMOHITO
优先权: 2007
US
CHEMICAL ENHANCEMENT BY NANOMATERIALS UNDER X-RAY IRRADIATION
US 2014371471 A1
申请人: UNIV CALIFORNIA
优先权: 2013
US
Nicotinic acid derivatives and preparation method and applications thereof
CN 107474043 A
申请人: XIAMEN INST OF RARE EARTH MAT
优先权: 2017
CN
Synthesis and application of novel s-guaiazulene sesquiterpenoid alkaloids
CN 110041246 A
申请人: OCEAN UNIV CHINA
优先权: 2018
CN
Preparation method and anti-tumor application of genistein amino acid ester derivatives
CN 109897024 A
申请人: UNIV SOUTH CHINA
优先权: 2019
CN
第 1 / 2 页
上一页
下一页
药物
反馈